Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein–Expressing Non–Small-Cell Lung Cancer

Authors: Camidge, D. Ross, Barlesi, Fabrice, Goldman, Jonathan W., Morgensztern, Daniel, Heist, Rebecca, Vokes, Everett, Spira, Alex, Angevin, Eric, Su, Wu-Chou, Hong, David S., Strickler, John H., Motwani, Monica, Dunbar, Martin, Parikh, Apurvasena, Noon, Elysa, Blot, Vincent, Wu, Jun, Kelly, Karen

Source: Journal of clinical oncology. 41(5):1105-1115

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100181430078.0x000001&indx=1&recIds=ETOCvdc_100181430078.0x000001

Considering Precision and Utility When we Talk About Pain. Comment on Cohen et al

Authors: Moseley, Graham L., Pearson, Neil, Reezigt, Roland, Madden, Victoria J., Hutchinson, Mark R., Dunbar, Martin, Beetsma, Anneke J., Leake, Hayley B., Moore, Pete, Simons, Laura, Heathcote, Lauren, Ryan, Cormac, Berryman, Carolyn, Mardon, Amelia K., Wand, Benedict M.

Source: Journal of pain. 24(1):178-181

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100178061653.0x000001&indx=1&recIds=ETOCvdc_100178061653.0x000001

Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Patients With Advanced Non–Squamous Non–Small Cell Lung Cancer

Authors: Govindan, Ramaswamy, Lind, Mike, Insa, Amelia, Khan, Saad A., Uskov, Dmitry, Tafreshi, Ali, Guclu, Salih, Bar, Jair, Kato, Terufumi, Lee, Ki Hyeong, Nakagawa, Kazuhiko, Hansen, Olfred, Biesma, Bonne, Kundu, Madan G., Dunbar, Martin, He, Lei, Ansell, Peter, Sehgal, Vasudha, Huang, Xin, Glasgow, Jaimee, Bach, Bruce A.

Source: Clinical lung cancer. 23(3):214-225

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100162457621.0x000001&indx=1&recIds=ETOCvdc_100162457621.0x000001

A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLC

Authors: Camidge, D. Ross, Barlesi, Fabrice, Goldman, Jonathan W., Morgensztern, Daniel, Heist, Rebecca, Vokes, Everett, Angevin, Eric, Hong, David S., Rybkin, Igor I., Barve, Minal, Bauer, Todd M., Delmonte, Angelo, Dunbar, Martin, Motwani, Monica, Parikh, Apurvasena, Noon, Elysa, Wu, Jun, Blot, Vincent, Kelly, Karen

Source: In JTO Clinical and Research Reports January 2022 3(1)

Veliparib and nivolumab in combination with platinum doublet chemotherapy in patients with metastatic or advanced non-small cell lung cancer: A phase 1 dose escalation study

Authors: Clarke, Jeffrey M., Patel, Jyoti D., Robert, Francisco, Kio, Ebenezer A., Thara, Eddie, Ross Camidge, D., Dunbar, Martin, Nuthalapati, Silpa, Dinh, Minh H., Bach, Bruce A.

Source: In Lung Cancer November 2021 161:180-188

Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study

Authors: DiNardo, Courtney D, Pratz, Keith W, Letai, Anthony, Jonas, Brian A, Wei, Andrew H, Thirman, Michael, Arellano, Martha, Frattini, Mark G, Kantarjian, Hagop, Popovic, Relja, Chyla, Brenda, Xu, Tu, Dunbar, Martin, Agarwal, Suresh K, Humerickhouse, Rod, Mabry, Mack, Potluri, Jalaja, Konopleva, Marina, Pollyea, Daniel A

Source: In The Lancet Oncology February 2018 19(2):216-228

Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma

Authors: Kumar, Shaji, Kaufman, Jonathan L., Gasparetto, Cristina, Mikhael, Joseph, Vij, Ravi, Pegourie, Brigitte, Benboubker, Lofti, Facon, Thierry, Amiot, Martine, Moreau, Philippe, Punnoose, Elizabeth A., Alzate, Stefanie, Dunbar, Martin, Xu, Tu, Agarwal, Suresh K., Enschede, Sari Heitner, Leverson, Joel D., Ross, Jeremy A., Maciag, Paulo C., Verdugo, Maria, Touzeau, Cyrille

Source: In Blood 30 November 2017 130(22):2401-2409

Smoking History Predicts Sensitivity to PARP Inhibitor Veliparib in Patients with Advanced Non–Small Cell Lung Cancer

Authors: Reck, Martin, Blais, Normand, Juhasz, Erzsebet, Gorbunova, Vera, Jones, C. Michael, Urban, Laszlo, Orlov, Sergey, Barlesi, Fabrice, Kio, Ebenezer, Keilholz, Ulrich, Qin, Qin, Qian, Jiang, Nickner, Caroline, Dziubinski, Juliann, Xiong, Hao, Mittapalli, Rajendar K., Dunbar, Martin, Ansell, Peter, He, Lei, McKee, Mark, Giranda, Vincent, Ramalingam, Suresh S.

Source: In Journal of Thoracic Oncology July 2017 12(7):1098-1108

Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites

Authors: Liu, Hong ^*, Michmerhuizen, Melissa J., Lao, Yanbin, Wan, Katty, Salem, Ahmed Hamed, Sawicki, James, Serby, Michael, Vaidyanathan, Srirajan, Wong, Shekman L., Agarwal, Suresh, Dunbar, Martin, Sydor, Jens, de Morais, Sonia M., Lee, Anthony J.

Source: In Drug Metabolism and Disposition March 2017 45(3):294-305

Management of Venetoclax-Posaconazole Interaction in Acute Myeloid Leukemia Patients: Evaluation of Dose Adjustments

Authors: Agarwal, Suresh K., DiNardo, Courtney D., Potluri, Jalaja, Dunbar, Martin, Kantarjian, Hagop M., Humerickhouse, Rod A., Wong, Shekman L., Menon, Rajeev M., Konopleva, Marina Y., Salem, Ahmed Hamed

Source: In Clinical Therapeutics February 2017 39(2):359-367

A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancer

Authors: van der Biessen, Diane A. J., Gietema, Jourik A., de Jonge, Maja J. A., Desar, Ingrid M. E., den Hollander, Martha W., Dudley, Matthew, Dunbar, Martin, Hetman, Robert, Serpenti, Camille, Xiong, Hao, Mittapalli, Rajendar K., Timms, Kirsten M., Ansell, Peter, Ratajczak, Christine K., Shepherd, Stacie Peacock, van Herpen, Carla M. L.

Source: Investigational new drugs. 36(5):828-835

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100127315858.0x000001&indx=1&recIds=ETOCvdc_100127315858.0x000001

Pharmacokinetics of venetoclax in patients with 17p deletion chronic lymphocytic leukemia

Authors: Salem, Ahmed Hamed, Dunbar, Martin, Agarwal, Suresh K.

Source: Anti-cancer drugs. 28(8):911-914

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100047876344.0x000001&indx=1&recIds=ETOCvdc_100047876344.0x000001

A more efficient Gibbs sampler estimation using steady-state simulation: applications to public health studies

Authors: Dunbar, Martin X., Samawi, Hani M., Vogel, Robert, Yu, Lili

Source: Journal of statistical computation and simulation. 84(9):1931-1945

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100036840679.0x000001&indx=1&recIds=ETOCvdc_100036840679.0x000001

Steady-state Gibbs sampler estimation for lung cancer data

Authors: Dunbar, Martin X., Samawi, Hani M., Vogel, Robert, Yu, Lili

Source: Journal of applied statistics. 41(5):977-988

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100033021271.0x000001&indx=1&recIds=ETOCvdc_100033021271.0x000001

Adherence to pharmacological treatment of non-malignant chronic pain: The role of illness perceptions and medication beliefs

Authors: Nicklas, Leeanne B., Dunbar, Martin, Wild, Matt

Source: Psychology & health. 25(5):601-615

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100110155076.0x000001&indx=1&recIds=ETOCvdc_100110155076.0x000001

MDS-141: The Prognostic Impact of Cytogenetic Scores in Patients with Higher-Risk Myelodysplastic Syndrome Treated with Venetoclax and Azacitidine in a Phase 1 Study

Authors: Garcia, Jacqueline S, Wei, Andrew H, Borate, Uma, Fong, Chun Yew, Baer, Maria R, Nolte, Florian, Peterlin, Pierre, Jurcic, Joseph, Jacoby, Meagan, Hong, Wan-Jen, Platzbecker, Uwe, Odenike, Olatoyosi, Cunningham, Ilona, Zhou, Ying, Dunbar, Martin, Harb, Jason G, Popovic, Relja, Tanwani, Poonam, Gopalakrishnan, Sathej, Wolff, Johannes, Garcia-Manero, Guillermo

Source: Clinical lymphoma, myeloma & leukemia. 20(S1):S315-S316

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100116347740.0x000001&indx=1&recIds=ETOCvdc_100116347740.0x000001

O7-4 Phase 1b efficacy of telisotuzumab vedotin and osimertinib in Asian vs non-Asian patients with advanced NSCLC

Authors: Horinouchi, Hidehito, Goldman, Jonathan, Cho, Byoung Chul, Tomasini, Pascale, Dunbar, Martin, Hoffman, David, Parikh, Apurvasena, Blot, Vincent, Camidge, D. Ross

Source: In Annals of Oncology November 2023 34 Supplement 3:S1387-S1387

O10-2 Telisotuzumab vedotin monotherapy in Asian patients with c-Met–overexpressing advanced non-small cell lung cancer

Authors: Horinouchi, Hidehito, Camidge, D. Ross, Bar, Jair, Goldman, Jonathan, Moiseenko, Fedor, Filippova, Elena, Cicin, Irfan, Bradbury, Penelope, Daaboul, Nathalie, Tomasini, Pascale, Ciuleanu, Tudor, Planchard, David, Moskovitz, Mor, Girard, Nicolas, Dunbar, Martin, Bolotin, Ellen, Looman, Jim, Ratajczak, Christine, Lu, Shun

Source: In Annals of Oncology November 2023 34 Supplement 3:S1388-S1388

A systematic review of economic analyses of psychological interventions and therapies in health-related settings.

Authors: Nicklas, Leeanne, Albiston, Mairi, Dunbar, Martin, Gillies, Alan, Hislop, Jennifer, Moffat, Helen, Thomson, Judy

Source: BMC Health Services Research; 9/7/2022, Vol. 22 Issue 1, p1-95, 95p, 1 Color Photograph, 66 Charts, 1 Graph

Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study.

Authors: LoRusso, Patricia, Ratain, Mark J., Doi, Toshihiko, Rasco, Drew W., de Jonge, Maja J. A., Moreno, Victor, Carneiro, Benedito A., Devriese, Lot A., Petrich, Adam, Modi, Dimple, Morgan-Lappe, Susan, Nuthalapati, Silpa, Motwani, Monica, Dunbar, Martin, Glasgow, Jaimee, Medeiros, Bruno C., Calvo, Emiliano

Source: Investigational New Drugs; Aug2022, Vol. 40 Issue 4, p762-772, 11p

Subject Terms: THERAPEUTIC use of antineoplastic agents, TREATMENT effectiveness, TUMORS, EVALUATION